Immunology

Personalizing targeted immunotherapy

This year may indeed be the year in which a class of immunotherapeutics called PD-1 and PD-L1 inhibitors are approved for a variety of cancers, as forecast recently by Drew Pardoll, MD, PhD, in a blog post. There is huge ...

Apr 30, 2015
popularity5 comments 0

Inflammatory immune cells can flip the genetic script

A type of immune cell that promotes inflammation during the immune response, TH17, can convert into another type of cell that reduces inflammation, Yale researchers have found. The finding, published April 29 in Nature, points ...

Apr 30, 2015
popularity29 comments 0